Genmab A/SGMABNASDAQ
Loading
Price to Sales: Discounted ValuationCompressed
Percentile Rank14
3Y CAGR-27.0%
5Y CAGR-20.3%
Year-over-Year Change
Price-to-sales ratio
3Y CAGR
-27.0%/yr
vs -10.7%/yr prior
5Y CAGR
-20.3%/yr
Recent deceleration
Acceleration
-16.3pp
Decelerating
Percentile
P14
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
1 yr
Consecutive growthCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 5.12 | +14.3% |
| 2024 | 4.48 | -47.5% |
| 2023 | 8.54 | -35.2% |
| 2022 | 13.18 | -35.0% |
| 2021 | 20.28 | +27.7% |
| 2020 | 15.88 | -8.7% |
| 2019 | 17.38 | -16.2% |
| 2018 | 20.75 | -23.7% |
| 2017 | 27.21 | -29.6% |
| 2016 | 38.67 | - |